A-share changes | Huada Intelligent Manufacturing (688114.SH) rose more than 8%, virtual cells moved towards engineering implementation, and the company teamed up with Baitu Biotech to bind AI Pharmaceuticals to next-generation infrastructure

The Zhitong Finance App learned that Huada Intelligent Manufacturing (688114.SH) rose more than 8% in the afternoon. As of press release, it had risen 7.36% to 58.37 yuan, with a turnover of 381 million yuan.

According to news, on September 11, Huada Zhizao, a global provider of full-stack life science tools, and Baitu Biotech, a global leader in basic life science models, reached a strategic cooperation: the two sides will jointly build an exclusive large cell model for specific customers and R&D scenarios, and use this as a foundation to develop an exclusive high-quality data output infrastructure for virtual cells and virtual disturbances. The AI4S base leader joined forces with the AI4S leading model to land the industry's most scarce high-quality data production capacity.

It is important to note that high-quality experimental data is the scarcest “fuel” for large models, and the ability to produce such data on a large scale is a core asset that Huada Intelligent Manufacturing has accumulated over many years. For Huada Intelligent Manufacturing, this collaboration means that its full-stack tool chain has once again become the “foundation” for cutting-edge research and development — cross-omics instruments and experimental systems have not only completed one-time experimental verification, but also accumulated high-quality real-world data on a large scale through continuous verification to feed back model iterations. In the future, the two sides will also promote standardization and commercialization of these joint capabilities and explore cooperation models such as “device+model+smart body” integrated products and AI CRO.